However, in cancer cells, alterations such as recurrent RSPO gene fusion or ZNRF3/RNF43 deletion or mutations disrupts this feedback loop, resulting in hyperactive WNT signaling and subsequent cancer development and progression (Seshagiri et al. 2012; Hao et al. 2016). This evidence concerns the gene RSPO1 and cancer.